Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript
Hello, and welcome to the Special Meeting of Stockholders of Ligand Pharmaceuticals Inc. Please note that today's meeting is being recorded. (Operator Instructions)
It is now my pleasure to turn today's meeting over to Charles Berkman, Senior Vice President, General Counsel and Secretary of Ligand Pharmaceuticals Incorporated. Mr. Berkman, the floor is yours.
Thank you. Welcome to Ligand's special meeting. I'm Charles Berkman, Ligand's General Counsel, and I will act as Chairman and Secretary for this meeting.
Due to the public health impact of the COVID-19 pandemic and to support the health and wellbeing of our stockholders, employees and their families, we are hosting this meeting in a virtual-only format. I hope everyone attending today's meeting and your families are safe and healthy.
I'd like to address 1 housekeeping matter before we begin. Registered stockholders or anyone who holds a valid proxy may submit comments or ask
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |